Jupiter Life Line Hospitals Ltd (JLHL) Q1 FY27 Results Analysis: PAT Slips 14.6%, Margin Pressure Persists

Jupiter Life Line Hospitals Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 410.98 Cr (+16.44% YoY) and PAT growth of -14.58% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

JLHL delivered strong revenue growth of 16.4% YoY, driven by the mature hospitals and the first full quarter from Dombivli. However, costs grew faster (22% YoY), compressing EBITDA margin by 293 bps and causing PAT to decline 14.6% YoY. The Dombivli ramp-up is on track as per management's guidance, but near-term margin pressure is expected to persist until occupancy improves.

Key Investment Insights

Key Positives

• Revenue grew 16.4% YoY to Rs.410.98 Cr, with standalone mature hospitals growing 18.2% YoY
• Dombivli contributed Rs.67 Cr revenue in its first full quarter, demonstrating early traction
• Effective tax rate fell to 25.80% from 28.83% YoY, partially cushioning PAT decline
• Leverage remains manageable at ~1.3x net debt/EBITDA, within the 3x ceiling
• Auditor's report unmodified opinion on standalone and consolidated results

Risk Factors

• EBITDA margin compressed 293 bps YoY to 19.29%, driven by cost growth outpacing revenue
• PAT declined 14.6% YoY to Rs.37.49 Cr, despite revenue growth
• Finance costs surged 55.5% YoY to Rs.12.86 Cr, reflecting higher debt for Dombivli
• Professional fees grew 23.6% YoY and other expenses grew 26.3% YoY, both faster than revenue
• Interest coverage compressed from ~9.5x to ~6.2x, increasing financial risk